Nuwellis, Inc. (NUWE) Climbs High with FDA Approval for Quelimmune
Wasim Omar
February 26, 2024
Nuwellis, Inc. (Nasdaq: NUWE) saw a modest 1.83% increase in trading on Friday. However, today’s premarket session reveals a significant uptick of 10%, indicating promising